Clinical decision-support suite (Aira) covering chest X-ray triage (qXR), emergency CT triage (qER, including large-vessel occlusion) across multiple regions.
Aira holds CE Class IIb marking (one of the first CDS platforms to obtain it); qER holds a 19th FDA clearance specifically for large-vessel occlusion detection.
Company press release on the CE Class IIb certification.
Named among TIME’s 100 Most Influential Companies (2025) — a third-party recognition, though not a clinical validation study; verify before publishing.
Claimed multi-country deployment across Africa and Asia in addition to USA/Europe — notable for low-resource-setting use, but exact site counts not found in this research pass.
No independently audited deployment figures found in this pass.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.